EPO Patents = 1

Forward Citations = 1

Loading Chart...

19 inventors (with patents filed for the assignee):

Yasuhiro Matsumura (4 out of 8 patents)

Masahiro Yasunaga (3 out of 7 patents)

Shinji Saijo (2 out of 2 patents)

4. Shingo Hanaoka (2 out of 5 patents)

5. Shino Manabe (2 out of 6 patents)

6. Ryo Tsumura (1 out of 2 patents)

7. Hirobumi Fuchigami (1 out of 1 patent)

8. Tetsuya Nakatsura (1 out of 11 patents)

9. Atsutaka Minagawa (1 out of 3 patents)

10. Shin Kaneko (1 out of 9 patents)

11. Shinji Saijou (1 out of 3 patents)

12. Yasushi Uemura (1 out of 3 patents)

13. Kyoko Fukuda (1 out of 2 patents)

14. Toshiaki Yoshikawa (1 out of 1 patent)

15. Atsushi Matsuda (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11633499 - Anti-TMEM-180 antibody, anticancer drug and cancer testing method (2023-04-25),

2. 11603519 - T-cell receptor (2023-03-14),

3. 11377504 - Antibody beneficial for treatment of solid tumors, antibody-drug conjugate, and cancer drug including same (2022-07-05),

4. 11311626 - Plasmin-cleavable anti-insoluble fibrin antibody-drug conjugate (2022-04-26),

5. 11192956 - Antibody binding to TMEM132A, anticancer agent, and cancer test method (2021-12-07),

National Cancer Center Japan is an organization dedicated to preventing and treating cancer through research, education, and patient care. They provide state-of-the-art cancer treatment and support services to patients and families, while also conducting innovative research to advance cancer prevention and treatment. With a focus on collaboration and excellence, National Cancer Center Japan is a leader in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#10 in Chuo-ku

#6,488 in Japan

Chuo-ku, Japan

National Cancer Center Japan